Literature DB >> 10752596

Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia.

A Rapaport1, M Sadeh, D Stein, J Levine, P Sirota, T Mosheva, S Stir, A Elitzur, I Reznik, D Geva, J M Rabey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10752596     DOI： 10.1002/1531-8257(200003)15:2<352::aid-mds1030>3.0.co;2-x

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  7 in total

1.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

Review 2.  Tardive Dyskinesia: Treatment Update.

Authors:  Divya Arya; Tarannum Khan; Adam J Margolius; Hubert H Fernandez
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-16       Impact factor: 5.081

3.  Tardive dyskinesia.

Authors:  Pratibha G Aia; Gonzalo J Revuelta; Leslie J Cloud; Stewart A Factor
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 4.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

Review 5.  Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.

Authors:  Dhanya Vijayakumar; Joseph Jankovic
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

Review 6.  Valbenazine for the Treatment of Adults with Tardive Dyskinesia.

Authors:  Harshit Gupta; Alycee R Moity; Allison Jumonville; Sarah Kaufman; Amber N Edinoff; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-18

Review 7.  Treatment of neurolept-induced tardive dyskinesia.

Authors:  Stacey K Jankelowitz
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.